All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Centers of Excellence in Cancer Communications Research | NCIT_C20851 | |
| Centers of Research Excellence | NCIT_C19983 | [Multidisciplinary and translational research teams focused on a specific disease, modality, biologic process or scientific area of particular significance. They are awarded sizeable amounts of flexible funding to enable them to rapidly address emerging scientific opportunities or specific challenges.] |
| Ectopic Tissue | NCIT_C132486 | [A tissue that forms in a location of the body at or in which it is not normally associated.] |
| Nurse Practitioner | NCIT_C20852 | [A registered nurse (RN) with advanced training in diagnosing and treating illness. NPs are master's degree prepared health experts that focus on helping patients achieve total health and prevent disease. NPs focus on disease prevention, wellness, and patient education. NPs prescribe medications, treat illness, and perform physical examinations. NPs can function independently of physician intervention, but require a practice agreement with a physician. NPs are licensed by a state authority.] |
| Eosinophilic Globules | NCIT_C132487 | [A cellular droplet comprising fibrin degradation products or intracytoplasmic proteinaceous accumulations that can be stained by eosin.] |
| Identity | NCIT_C68806 | [The set of characteristics by which a thing or person is recognized or known and that constitutes it's individuality or set inclusion.] |
| Sickness | NCIT_C107499 | [A state of ill health, bodily malfunction, or discomfort.] |
| Bone Response | NCIT_C132455 | [An assessment of the bone response of a disease to a therapy.] |
| Heavy | NCIT_C68807 | [Of comparatively great physical weight or density.] |
| Metastatic Disease Indicator | NCIT_C132456 | [An indication as to whether a malignancy has appeared at sites distant to the primary site of disease.] |
| Light | NCIT_C68808 | [Of comparatively little physical weight or density.] |
| Soft Tissue Response | NCIT_C132457 | [An evaluation of the soft tissue response of the disease to the therapy.] |
| PeptideProphet | NCIT_C68809 | [A software package for the statistical validation of peptide identifications made by tandem mass spectrometry (MS/MS) and database searching.] |
| Tumor Marker Response | NCIT_C132458 | [An evaluation of the tumor marker response of the disease to the therapy.] |
| Clinical Nursing | NCIT_C20868 | [Clinical nursing applies the skills and processes of nursing to patients in an acute care environment.] |
| Nursing | NCIT_C16926 | [Nursing encompasses autonomous and collaborative care of individuals of all ages, families, groups and communities, sick or well and in all settings. Nursing includes the promotion of health, prevention of illness, and the care of ill, disabled and dying people. Advocacy, promotion of a safe environment, research, participation in shaping health policy and in patient and health systems management, and education are also key nursing roles. (ICN 2002)] |
| Primary Language Spoken | NCIT_C132459 | [The main language that is spoken by the subject most frequently or dominantly.] |
| Hospital Nursing | NCIT_C20869 | [The provision of professional nursing care in an inpatient setting.] |
| Monoclonal Antibody 48.7 F(ab) | NCIT_C29200 | [A Fab fragment of the mouse monoclonal antibody (MoAb) 48.7. MoAb 48.7 Fab (fragment antigen binding) recognizes proteoglycan antigen expressed on the cell surface of melanoma cells. The Fab fragments are obtained through papain digestion in the presence of cysteine. The advantage of using MoAb 48.7 Fab fragments over whole antibodies is that they have reduced immunogenicity, better penetration of tissues, rapid clearance from the body and that they do not induce precipitation.] |
| Monoclonal Antibody 528 | NCIT_C29201 | [A monoclonal antibody against the epidermal growth factor receptor (EGFR). EGFR is a tyrosine kinase overexpressed or upregulated in various types of cancer. By binding to EGFR, monoclonal antibody 528 specifically inhibits the activity of the EGFR tyrosine kinase. (NCI04)] |